Combined use of positron emission tomography with 18F- fluorodeoxyglucose and 11C-methionine for preoperative evaluation of gliomas

Neurological Surgery

Volumn 38, Issue 7, 2010, Pages 621-628

  Yamaguchi, Shigeru ^a   Terasaka, Shunsuke ^a   Kobayashi, Hiroyuki ^a   Narita, Takuhito ^a   Hirata, Kenji ^a   Shiga, Satoshi ^a   Usui, Reiko ^a   Tanaka, Shinya ^a   Kubota, Kanako ^b   Murata, Junichi ^c   Asaoka, Katsuyuki ^d  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c Sapporo Azabu Neurosurgical Hospital   (Japan)

^d TEINE KEIJINKAI HOSPITAL   (Japan)

Author keywords

Fluorodeoxyglucose; Glioma; Methionine; Positron emission tomography; Preoperative evaluation

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHIONINE C 11;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; GLIOMA; HUMAN; POSITRON EMISSION TOMOGRAPHY; RECURRENT DISEASE; TUMOR GROWTH; TUMOR LOCALIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; MALE; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; RADIOPHARMACEUTICALS;

EID: 77954630045     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W. Relvich M : Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62 : 1074-1078, 1988
2. Borbely K, Nyary I, Toth M, Ericson K, Gulyas B : Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci 246 : 85-94, 2006
3. Chen W : Clinical applications of PET in brain tumors. J Nucl Med 48: 1468-1481, 2007 (Pubitemid 47397397)
4. De Witte O. Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I, Brotchi J, Goldman S : Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95 : 746-750, 2001
5. Galldiks N, Kracht LW, Burghaus L, Thomas A, Jacobs AH, Heiss WD, Herholz K : Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. Eur J Nucl Med Mol Imaging 33 : 516-524, 2006
6. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Dethy S, Brotchi J, Hildebrand J : Regional methionine and glucose uptake in high-grade gliomas : a comparative study on PET-guided stereotactic biopsy. J Nucl Med 38 : 1459-1462, 1997
7. Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, Mendoza G, Weber-Luxenburger G, Lottgen J, Thiel A, Wienhard K, Heiss WD : 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50 : 1316-1322, 1998
8. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ. Piers DA : Radiolabeled amino acids : basic aspects and clinical applications in oncology. J Nucl Med 42 : 432-445, 2001 (Pubitemid 32207394)
9. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, Luxen A, Reznik M : Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39 : 778-785, 1998
10. Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T : Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29: 1176-1182, 2008
11. Kato T, Shinoda J, Oka N, Miwa K, Nakayama N, Yano H, Maruyama T, Muragaki Y, Iwama T : Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity. AJNR Am J Neuroradiol 29 : 1867-1871, 2008
12. Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC : 11C-methionine PET as a prognostic marker in patients with glioma : comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 32 : 52-59, 2005
13. Kracht LW, Miletic H, Busch S, Jacobs AH, Voges J, Hoevels M, Klein JC, Herholz K, Heiss WD : Delineation of brain tumor extent with [11C]L-methionine positron emission tomography : local comparison with stereotactic histopathology. Clin Cancer Res 10 : 7163-7170, 2004
14. Kubota K : From tumor biology to clinical Pet : a review of positron emission tomography (PET) in oncology. Ann Nucl Med 15 : 471-486, 2001
15. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T : Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo : high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 : 1972-1980, 1992
16. Langen KJ, Muhlensiepen H, Holschbach M, Hautzel H, Jansen P, Coenen HH : Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line : comparison with [3H]methyl]-L-methionine. J Nucl Med 41 : 1250-1255, 2000
17. Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, Senda M, Ishii K, Hirakawa K, Ohno K : Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103 : 498-507, 2005
18. Nojiri T, Nariai T. Aoyagi M, Senda M, Ishii K. Ishiwata K, Ohno K : Contributions of biological tumor parameters to the incorporation rate of L : -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas. J Neurooncol 93 : 233-241, 2009
19. Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E, Norrgard S, Kulmala J, Teras M, Minn H : Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. Int J Radiat Oncol Biol Phys 48 : 43-52, 2000
20. Ogawa T, Inugami A, Hatazawa J, Kanno I, Murakami M, Yasui N, Mineura K, Uemura K : Clinical positron emission tomography for brain tumors : comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. AJNR Am J Neuroradiol 17 : 345-353, 1996
21. Ohgaki H, Kleihues P : Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64 : 479-489, 2005 (Pubitemid 40781150)
22. Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schuler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lutolf UM, Kleihues P, Ohgaki H : Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108 : 49-56, 2004
23. Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, Christian B, Ruppert J, Bernstein T, Kraus G, Mantil JC : Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 64 : 227-237, 2003
24. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M : Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors : a report of 103 consecutive procedures. J Neurosurg 104 : 238-253, 2006
25. Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A, Salmon I, Brotchi J, Levivier M : Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 45 : 1293-1298, 2004
26. Pirotte BJ, Levivier M, Goldman S, Massager N, Wikler D, Dewitte O, Bruneau M, Rorive S, David P, Brotchi J : Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas : a survival analysis in 66 consecutive patients. Neurosurgery 64 : 471-481 ; discussion 481, 2009
27. Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, Bolander H, Bergstrom M, Smits A : Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 92 : 1541-1549, 2001
28. Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Fukumura T, Mihara F, Morioka T, Fukui M, Masuda K : A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 25 : 1261-1269, 1998
29. Schifter T, Hoffman JM, Hanson MW, Boyko OB, Beam C, Paine S, Schold SC, Burger PC, Coleman RE : Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 17 : 509-561, 1993
30. Strauss LG, Conti PS : The applications of PET in clinical oncology. J Nucl Med 32 : 623-648 ; discussion 649-650,1991
31. Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, Bormans G, Mortelmans L : Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma : sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 32 : 39-51, 2005